Related Experiment Videos
New antimicrobial agents
1Department of Infectious Diseases, Cleveland Clinic Foundation, Ohio, USA.
Insights
Antimicrobial resistance is a growing threat, particularly in pediatrics, necessitating judicious use of antibiotics. Public education and physician stewardship are crucial to combat the spread of resistant bacteria.
Area of Science:
- Microbiology and Infectious Diseases
- Pediatrics
- Public Health
Background:
- The emergence of antibiotic-resistant bacteria poses a significant threat to public health.
- Pediatric infections like otitis media are increasingly caused by resistant strains, such as penicillin-resistant *Streptococcus pneumoniae*.
- Methicillin-resistant *Staphylococcus aureus* (MRSA) and vancomycin-resistant enterococci (VRE) present growing challenges in both community and hospital settings.
Purpose of the Study:
- To highlight the growing concern of antimicrobial resistance.
- To discuss the implications of resistance in pediatric populations.
- To advocate for responsible antimicrobial stewardship and public education.
Main Methods:
- Review of current trends in antimicrobial resistance.
- Analysis of the impact of antibiotic use on resistance patterns.
- Discussion of clinical implications and public health strategies.
Main Results:
- Increasing frequency of penicillin-resistant pneumococci in children.
- Rising incidence of MRSA in community and nosocomial infections.
- Emergence of VRE, with limited treatment options, linked to vancomycin use.
Conclusions:
- Combating antimicrobial resistance requires a concerted effort from physicians and the public.
- Limiting inappropriate use of antibiotics, including for viral infections, is essential.
- Stewardship programs, updated guidelines, and public education are critical to preserve antibiotic efficacy.
Abstract:
In any discussion of new antimicrobial agents in the 1990s, a warning and a plea are necessary. The spreading emergence of resistance among bacteria raises concerns for the effectiveness of antimicrobial therapy. Penicillin-resistant pneumococci are probably of most significance in pediatrics and are increasing in frequency, in part related to the use of antimicrobial therapy in young children to treat such infections as otitis media. New practice guidelines have suggested the more limited use of antimicrobial agents in treating serious otitis media. When pediatricians do treat, they should select effective agents. Limiting therapy to brief courses with effective and narrow-spectrum agents may be helpful also. Treating long enough to ensure eradication in serious infections is equally important. Methicillin-resistant S aureus are also increasing and are increasingly a concern in community-acquired infections and nosocomial infections. Using topical agents, such as mupirocin, to treat impetigo and other superficial skin infections can limit exposure to systemic agents and may delay the spread of resistance. Vancomycin-resistant enterococcal infections, an infrequent pediatric problem, are most frightening because no alternative therapies are available. Their occurrence is directly related to use of vancomycin in the communities that are affected. Containing the spread of drug-resistant bacteria will likely require a concerted effort by both physicians and the public. The indiscriminate use of antimicrobial agents to treat non-bacterial infections should be contained. The public must be educated to understand that antimicrobial agents are ineffective against viral infections. In the setting of managed care, educating administrators who make practice decisions that cheaper is not always better will be crucial. The issues of day-care infections and spread of potential pathogens must take on increasing attention and methods to decrease infection sought. Curbing inappropriate use of antimicrobial agents will be as important as learning the nuances between new agents.